Ignacio
Gil Bazo
Researcher to 2022
Fundación Jiménez Díaz
Madrid, EspañaPublications in collaboration with researchers from Fundación Jiménez Díaz (5)
2023
-
Brief report: High incidence of peridiagnosis thromboembolic events in patients with BRAF-mutant lung cancer
Thrombosis Research, Vol. 232, pp. 133-137
-
Integration of longitudinal deep-radiomics and clinical data improves the prediction of durable benefits to anti-PD-1/PD-L1 immunotherapy in advanced NSCLC patients
Journal of Translational Medicine, Vol. 21, Núm. 1
2022
-
MCLA-129, a human anti-EGFR and anti-c-MET bispecific antibody, in patients with advanced NSCLC and other solid tumors: an ongoing phase 1/2 study
European Journal of Cancer, Vol. 174, pp. S122
2021
-
Delta-radiomics signature for prediction of survival in advanced nsclc patients treated with immunotherapy
Proceedings - International Symposium on Biomedical Imaging
2012
-
Role of flow cytometry immunophenotyping in the diagnosis of leptomeningeal carcinomatosis
Neuro-Oncology, Vol. 14, Núm. 1, pp. 43-52